🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Glaucoma is the leading cause of irreversible blindness worldwide. Previous...
Status
Terminated
Location
University of California, San Francisco
Start Date
2022-10-10
Trial ID
NCT05273385
Treatments Being Tested
The goal of this clinical trial is to compare the onset and duration of num...
Status
Completed
Location
Columbia University Irving Medical Center
Start Date
2024-12-12
Trial ID
NCT06636708
Treatments Being Tested
Prescription eye drop bottles elute drops that exceed the capacity of the h...
Status
Completed
Location
University of California, San Francisco
Start Date
2021-07-29
Trial ID
NCT05274321
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, and usabilit...
Status
Unknown
Location
University of Washington
Start Date
2022-02-28
Trial ID
NCT05277870
Treatments Being Tested
This randomized, single-masked, crossover, non-inferiority trial aims to ev...
Status
Recruiting
Location
Wilford Hall Ambulatory Surgical Center
Start Date
2022-03-17
Trial ID
NCT05844384
Treatments Being Tested
The average drop size produced by standard eyedrop bottle exceeds the maxim...
Status
Completed
Location
Lions Eye Clinic
Start Date
2022-01-04
Trial ID
NCT06689904
Treatments Being Tested
The purpose is to test the hypothesis that microdrop instillation of cyclop...
Status
Completed
Location
Papageorgiou General Hospital
Start Date
2024-09-06
Trial ID
NCT06885242
Treatments Being Tested
Glaucoma medications are vital to disease management and prevention of furt...
Status
Not Yet Recruiting
Location
Yawkey Eye Clinic, Boston Medical Center
Start Date
2026-10
Trial ID
NCT06806332
Treatments Being Tested
The purpose of this study is to evaluate the effect of microdrops vs. stand...
Status
Completed
Location
Aravind Eye Hospital
Start Date
2021-11-06
Trial ID
NCT05181046
Treatments Being Tested